Schizophrenia, tardive dyskinesia, and brain GABA
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 25 (2) , 200-206
- https://doi.org/10.1016/0006-3223(89)90164-9
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Clinical and biochemical effects of gamma-vinyl Gaba in tardive dyskinesia.Journal of Neurology, Neurosurgery & Psychiatry, 1987
- Neurotransmitter amino acids in post-mortem brains of chronic schizophrenic patientsPsychiatry Research, 1987
- CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controlsAmerican Journal of Psychiatry, 1984
- Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesisNature, 1984
- The Effect of Tetrahydroisoxazolopyridinol (THIP) in Tardive DyskinesiaArchives of General Psychiatry, 1982
- Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunctionNeuroscience Letters, 1982
- γ‐Aminobutyric Acid Concentration in Cerebrospinal Fluid in SchizophreniaJournal of Neurochemistry, 1981
- Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophreniaNeuroscience Letters, 1980
- GAMMA-AMINOBUTYRIC ACID IN THE BRAIN IN SCHIZOPHRENIAThe Lancet, 1979
- Gamma-Aminobutyric Acid (GABA) in the CSF of Schizophrenic Patients Before and After Neuroleptic TreatmentThe British Journal of Psychiatry, 1978